Literature DB >> 26823791

Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.

Xiao-Xia Li1, Rui-Jian Li2, Lu-Jun Zhao1, Ning-Bo Liu1, Ping Wang1.   

Abstract

Distant metastasis continues to be a fatal threat to quality of life in patients with small cell lung caner (SCLC). The purpose of this work is to analyze the expressions of chemokine receptor four (CXCR4), matrix metalloproteinase-9 (MMP-9), transforming growth factor-b1 (TGF-β1), N-cadherin and vascular endothelial growth factor (VEGF) in small cell lung caner (SCLC), and to explore their correlations with the prognosis and metastasis. Sixty-five consecutive patients with stage I-III SCLC who received operation in our hospital from Jan 2003 to Oct 2009 were retrospectively analyzed. The expression of CXCR4 was found significantly correlated with bone metastasis (P = 0.004), and were marginally correlated with brain metastasis (P = 0.068) and lymph node metastasis (P = 0.085). The expression of MMP-9 was significantly associated with pathological staging (P = 0.048). Univariate analysis suggested surgical approach, clinical stage, lymph node metastasis were significantly associated with OS and PFS (P < 0.05), high expression of CXCR4 was significantly correlated with worse OS (P = 0.004) and PFS (P = 0.005). Multivariate analysis suggested surgical approach, TGF-β1, CXCR4 and lymph node metastasis were independent prognostic factor for PFS. In conclusion, High expression of CXCR4, MMP-9, TGF-β1 and VEGF were found in SCLC. High expression of MMP-9 was significantly associated with pathological staging, and high expression of CXCR4 was correlated with bone metastasis and also might correlate with brain metastasis. CXCR4 were independent prognostic factor for survival in SCLC and expanded samples should be further explored in the future.

Entities:  

Keywords:  Small cell lung cancer; immunohistochemistry; metastasis; molecular factors; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26823791      PMCID: PMC4713577     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.

Authors:  Suqin Zheng; Yanhe Chang; Kurt B Hodges; Ying Sun; Xiaobing Ma; Yi Xue; Sean R Williamson; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Anticancer Res       Date:  2010-03       Impact factor: 2.480

2.  Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.

Authors:  Nicole Hahn; Margarethe Heiden; Rainer Seitz; Ursula Salge-Bartels
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

3.  Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.

Authors:  J Safranek; M Pesta; L Holubec; V Kulda; J Dreslerova; J Vrzalova; O Topolcan; M Pesek; J Finek; V Treska
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

4.  Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.

Authors:  Yan-Xi Sun; Abraham Schneider; Younghun Jung; Jianhua Wang; Jinlu Dai; Jingcheng Wang; Kevin Cook; Nadir I Osman; Amy J Koh-Paige; Hyusuk Shim; Kenneth J Pienta; Evan T Keller; Laurie K McCauley; Russell S Taichman
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

5.  TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.

Authors:  Miao Yin; Johanna Soikkeli; Tiina Jahkola; Susanna Virolainen; Olli Saksela; Erkki Hölttä
Journal:  Am J Pathol       Date:  2012-10-10       Impact factor: 4.307

6.  Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.

Authors:  Tatjana Seute; Pieter Leffers; Guul P M ten Velde; Albert Twijnstra
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

Review 7.  Biological activity and clinical implications of the matrix metalloproteinases.

Authors:  M Rydlova; L Holubec; M Ludvikova; D Kalfert; J Franekova; C Povysil; M Ludvikova
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480

8.  Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.

Authors:  Meike Burger; Aleksandra Glodek; Tanja Hartmann; Anette Schmitt-Gräff; Leslie E Silberstein; Nobutaka Fujii; Thomas J Kipps; Jan A Burger
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

9.  Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer.

Authors:  Yuanyuan Gao; Yan Wang; Lichun Sun; Qingwei Meng; Li Cai; Xiaoqun Dong
Journal:  Tumour Biol       Date:  2014-06-20

10.  High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer.

Authors:  Lunqing Wang; Zhou Wang; Xiangyan Liu; Fanying Liu
Journal:  Oncol Lett       Date:  2014-03-18       Impact factor: 2.967

View more
  8 in total

Review 1.  Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.

Authors:  Takaaki Ito; Shinji Kudoh; Takaya Ichimura; Kosuke Fujino; Wael Ahmed Maher Abdo Hassan; Naoko Udaka
Journal:  Hum Cell       Date:  2016-10-26       Impact factor: 4.174

2.  The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.

Authors:  Liping Qiu; Yuanyuan Xu; Hui Xu; Biyun Yu
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

Review 3.  Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.

Authors:  Yong Luo; Ting Yu; Qiongwen Zhang; Qingyu Fu; Yuzhu Hu; Mengmeng Xiang; Haoning Peng; Tianying Zheng; Li Lu; Huashan Shi
Journal:  Eur J Clin Invest       Date:  2018-02-25       Impact factor: 4.686

Review 4.  Cancer and the metastatic substrate.

Authors:  Francisco Arvelo; Felipe Sojo; Carlos Cotte
Journal:  Ecancermedicalscience       Date:  2016-12-08

5.  miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.

Authors:  Yanqin Sun; Bingshuang Hu; Yanhong Wang; Zhen Li; Jingfang Wu; Yunchu Yang; Yue Wei; Xiaofeng Peng; Hongling Chen; Rongqi Chen; Pingyan Jiang; Sixian Fang; Zhiwu Yu; Linlang Guo
Journal:  Cancer Manag Res       Date:  2018-10-18       Impact factor: 3.989

6.  Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.

Authors:  Rui-Xue Tang; Wen-Jie Chen; Rong-Quan He; Jiang-Hui Zeng; Liang Liang; Shi-Kang Li; Jie Ma; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-04-13

7.  RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.

Authors:  Nneha Sakre; Gary Wildey; Mohadese Behtaj; Adam Kresak; Michael Yang; Pingfu Fu; Afshin Dowlati
Journal:  Oncotarget       Date:  2017-01-24

Review 8.  Mechanisms of small cell lung cancer metastasis.

Authors:  Julie Ko; Monte M Winslow; Julien Sage
Journal:  EMBO Mol Med       Date:  2020-12-09       Impact factor: 14.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.